142 related articles for article (PubMed ID: 29969609)
21. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
22. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
[TBL] [Abstract][Full Text] [Related]
23. High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway.
Liu N; Shi S; Deng M; Tang L; Zhang G; Liu N; Ding B; Liu W; Liu Y; Shi H; Liu L; Jin Y
J Bone Miner Res; 2011 Sep; 26(9):2082-95. PubMed ID: 21638320
[TBL] [Abstract][Full Text] [Related]
24. The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases.
Mariz K; Ingolf JB; Daniel H; Teresa NJ; Erich-Franz S
Clin Exp Metastasis; 2015 Dec; 32(8):857-66. PubMed ID: 26420587
[TBL] [Abstract][Full Text] [Related]
25. Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway.
Liu X; Li L; Lv L; Chen D; Shen L; Xie Z
Oncol Rep; 2015 Aug; 34(2):1035-41. PubMed ID: 26035210
[TBL] [Abstract][Full Text] [Related]
26. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
[TBL] [Abstract][Full Text] [Related]
27. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
28. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
Vilchez V; Turcios L; Marti F; Gedaly R
World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
[TBL] [Abstract][Full Text] [Related]
29. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
30. Indirubin-3'-oxime, an activator of Wnt/β-catenin signaling, enhances osteogenic commitment of ST2 cells and restores bone loss in high-fat diet-induced obese male mice.
Zahoor M; Cha PH; Choi KY
Bone; 2014 Aug; 65():60-8. PubMed ID: 24815917
[TBL] [Abstract][Full Text] [Related]
31. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
[TBL] [Abstract][Full Text] [Related]
32. Skeletal metastasis: treatments, mouse models, and the Wnt signaling.
Valkenburg KC; Steensma MR; Williams BO; Zhong Z
Chin J Cancer; 2013 Jul; 32(7):380-96. PubMed ID: 23327798
[TBL] [Abstract][Full Text] [Related]
33. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
34. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
[TBL] [Abstract][Full Text] [Related]
35. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
[TBL] [Abstract][Full Text] [Related]
36. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
37. Suppression of osteogenic activity by regulation of WNT and BMP signaling during titanium particle induced osteolysis.
Nam JS; Sharma AR; Jagga S; Lee DH; Sharma G; Nguyen LT; Lee YH; Chang JD; Chakraborty C; Lee SS
J Biomed Mater Res A; 2017 Mar; 105(3):912-926. PubMed ID: 28076890
[TBL] [Abstract][Full Text] [Related]
38. Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis.
Lee JH; Cho HS; Lee JJ; Jun SY; Ahn JH; Min JS; Yoon JY; Choi MH; Jeon SJ; Lim JH; Jung CR; Kim DS; Kim HT; Factor VM; Lee YH; Thorgeirsson SS; Kim CH; Kim NS
Oncotarget; 2016 Nov; 7(48):79774-79786. PubMed ID: 27806330
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells.
Zou Y; Yang J; Jiang D
Mol Med Rep; 2015 Nov; 12(5):7221-6. PubMed ID: 26398440
[TBL] [Abstract][Full Text] [Related]
40. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
Nishiya N
Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
